step 1 semaglutide 2.4 mg weight loss percent clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE) Tirzepatide vs semaglutide dosage chart:

Appetite Suppression via Hypothalamic Signaling: GLP-1 receptor agonists reduce appetite by acting on the hypothalamic arcuate nucleus and slowing gastric emptying, thereby slowing caloric absorption

These findings collectively elucidate that gut dysbiosis, marked by a decline in anti-inflammatory and short-chain fatty acid (SCFA)-producing bacteria, exacerbates metabolic and hormonal disturbances in PCOS

Feel Confident

This dual-axis attack on energy balance simultaneously reducing input and increasing output may be responsible for the sustained slope of weight loss that was not observed with single or dual-agonist compounds in comparable timelines